Effect of Single vs Repeated Cycles of a Combination of Granulocyte Colony Stimulating Factor and Darbepoetin vs Standard Medical Treatment on Immunometabolic Profile in Patient With Early Decompensated Cirrhosis.

Abroad (travel likely)Recruiting

Conditions

Decompensated Liver Cirrhosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Institute of Liver & Biliary Sciences (ILBS), New Delhi, National Capital Territory of Delhi, India
Contact: Study coordinator (Dr Shreya Singh, MD) · shreyasingh2746@gmail.com · 01146300000

Study leads

Dr Manoj Kumar Sharma, DM
Study Director
Institute of Liver and Biliary Sciences

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT Trial).

Liver Cirrhosis · Decompensated Cirrhosis of Liver · Acute on Chronic Liver Failure (ACLF)

Abroad (travel likely)RecruitingPHASE2

Clichy, France · Aachen, Germany

Albumin Assisted Diuresis in Patients with Cirrhosis and Ascites

Cirrhosis · Ascites Hepatic

Abroad (travel likely)RecruitingPHASE2

West Haven, United States

Statin and Beta Blocker Use in Patients With Decompensated Cirrhosis

Decompensated Liver Cirrhosis · Cirrhosis · Decompensated Cirrhosis of Liver

Abroad (travel likely)RecruitingPHASE2

Charleston, United States

RTX001 Autologous Engineered Macrophages for Liver Cirrhosis

End-stage Liver Disease (ESLD) · Cirrhosis, Liver · Cirrhosis, Decompensated

Abroad (travel likely)RecruitingPHASE1, PHASE2

Barcelona, Spain · Córdoba, Spain